AstraZeneca plc 

(Public, LON:AZN)   Watch this stock   
Find more results forAZN

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 25.87% 19.40%
Operating margin 39.07% 28.94%
EBITD margin - 34.84%
Return on average assets 16.66% 12.94%
Return on average equity 45.62% 39.76%
Employees 65,000 -

Address

15 Stanhope Gate
London, ENG W1K 1LN
United Kingdom - Map
+44-20-73045000 (Phone)
+44-20-73045151 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

AstraZeneca plc discussed on blogs

- Guncelim - noreply@blogger.com (yagmurunsesi) - Guncelim - 6 hours ago
Ranking 300+ Large Cap Stocks by Earnings Growth Potential ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 24, 2009

AstraZeneca plc discussions

  View all discussions »

Description

AstraZeneca PLC is a United Kingdom-based pharmaceutical company, which discovers, develops, manufactures and markets prescription pharmaceuticals, biologics and vaccines for areas of healthcare, such as cardiovascular, gastrointestinal, infection, neuroscience, oncology, respiratory and inflammation. Its product range includes Arimidex, Crestor, Nexium, Seroquel and Symbicort. The Company has 26 manufacturing sites in 18 countries. On October 10, 2007, the Company’s subsidiary, Astra Tech, acquired Atlantis Components Inc. Astra Tech is engaged in the research, development, manufacture and marketing of medical devices and implants for use in healthcare, primarily in urology, surgery and odontology.

Officers and directors

David R. Brennan
Chief Executive Officer, Executive Director
Age: 55
Simon Lowth
Chief Financial Officer, Executive Director
Age: 47
Bruno Angelici
Executive Vice President - International Sales and Marketing Organisation
Tony Zook
EVP - Global Marketing and CEO, North America; President of MedImmune
Lynn Tetrault
Executive Vice President - Human Resources and Corporate Affairs
David Smith
Executive Vice President - Operations
Anders Ekblom
Executive Vice President - Development
Jeffrey Pott
General Counsel
Adrian C.N. Kemp
Company Secretary
Louis Schweitzer
Non-Executive Chairman of the Board
Age: 67